OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS

The paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between...

Full description

Bibliographic Details
Main Authors: O. Yu. Shaidyuk, E. O. Taratukhin
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2013-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/95
_version_ 1827063890218844160
author O. Yu. Shaidyuk
E. O. Taratukhin
author_facet O. Yu. Shaidyuk
E. O. Taratukhin
author_sort O. Yu. Shaidyuk
collection DOAJ
description The paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between ACEI and acetylsalicylic acid, as well as the results of international multi-centre studies.
first_indexed 2024-04-10T03:37:10Z
format Article
id doaj.art-49677f2fba494e06a228b060b356beaf
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2025-03-19T22:38:26Z
publishDate 2013-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-49677f2fba494e06a228b060b356beaf2024-10-17T12:21:33Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-12-01126212310.15829/1728-8800-2013-6-21-2395OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITSO. Yu. Shaidyuk0E. O. Taratukhin1N.I. Pirogov Russian National Medical Research University, MoscowN.I. Pirogov Russian National Medical Research University, MoscowThe paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between ACEI and acetylsalicylic acid, as well as the results of international multi-centre studies.https://cardiovascular.elpub.ru/jour/article/view/95prostaglandinsendotheliumbradykinincoronary heart diseaserenal
spellingShingle O. Yu. Shaidyuk
E. O. Taratukhin
OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
Кардиоваскулярная терапия и профилактика
prostaglandins
endothelium
bradykinin
coronary heart disease
renal
title OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
title_full OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
title_fullStr OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
title_full_unstemmed OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
title_short OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
title_sort off target effects of angiotensin converting enzyme inhibitors additional therapeutic benefits
topic prostaglandins
endothelium
bradykinin
coronary heart disease
renal
url https://cardiovascular.elpub.ru/jour/article/view/95
work_keys_str_mv AT oyushaidyuk offtargeteffectsofangiotensinconvertingenzymeinhibitorsadditionaltherapeuticbenefits
AT eotaratukhin offtargeteffectsofangiotensinconvertingenzymeinhibitorsadditionaltherapeuticbenefits